The lawsuit is sealed so as not to violate the companies’ confidentiality agreement, according to the report. Sources told WSJ the lawsuit alleges Theranos misrepresented the readiness of its technology when it struck a deal with the drug retailer and continued to do so as doubts were raised over the past year about Theranos technology.
Walgreens ended its three-year partnership with Theranos in June after the blood testing startup voided tens of thousands of tests and issued corrections. Walgreens had Theranos blood-draw sites in 40 stores in Arizona and one in California.
“We are disappointed that Walgreens filed this lawsuit. Over the years, Walgreens consistently failed to meet its commitments to Theranos,” the company wrote in a statement on the lawsuit. “Through its mishandling of our partnership and now this lawsuit, Walgreens has caused Theranos and its investors significant harm. We will respond vigorously to Walgreens’ unfounded allegations, and will seek to hold Walgreens responsible for the damage it has caused to Theranos and its investors.”
More articles on legal and regulatory issues:
Judge sentences surgical technician who switched syringes at Swedish Medical Center
6 latest lawsuits involving hospitals
Judge approves Connecticut hospital’s $107M pension fund settlement
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
